Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.14
-0.0900-2.13%
Post-market: 4.140.00000.00%19:30 EDT
Volume:762.57K
Turnover:3.19M
Market Cap:129.54M
PE:-1.00
High:4.29
Open:4.23
Low:4.12
Close:4.23
52wk High:50.40
52wk Low:4.12
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.00
T/O Rate:4.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.59
PE(LYR):-1.45

Loading ...

Top Executive Makes a Major Move at Aquestive Therapeutics

TIPRANKS
·
31 mins ago

Eterna Therapeutics Updates Investors With New Corporate Materials

TIPRANKS
·
4 hours ago

Eterna Therapeutics appoints independent director Robert J. Spiegel

TIPRANKS
·
5 hours ago

Tempest Therapeutics Adjourns Meeting on Governance Changes

TIPRANKS
·
5 hours ago

Cardiol Therapeutics receives over $7M in proceeds from warrant exercise

TIPRANKS
·
Yesterday

Press Release: Cardiol Therapeutics Announces Warrant Exercise for over USD $7 Million in Proceeds

Dow Jones
·
Yesterday

Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target

MT Newswires Live
·
Yesterday

Revive Therapeutics Moves to Build Global Bucillamine Franchise in Biodefence and Rare Diseases

TIPRANKS
·
Yesterday

Allarity Therapeutics is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Yesterday

Alterity Therapeutics Seeks Quotation for New ASX Shares

TIPRANKS
·
Yesterday

Top Oruka Therapeutics Insiders Quietly Cash Out in Major Stock Moves

TIPRANKS
·
Yesterday

Decoy Therapeutics Shareholders Approve Key Capital Structure Changes

TIPRANKS
·
Yesterday

Tempest Therapeutics Gains Option to License New In-Body CAR-T Technology From Senlang

MT Newswires Live
·
Yesterday

Tempest Therapeutics Announces New Private Warrant Financing

TIPRANKS
·
Yesterday

Coya Therapeutics Price Target Maintained with a $16.00/Share by BTIG

Dow Jones
·
Yesterday

Summit Therapeutics Highlights Positive Ivonescimab Phase III Survival Data

TIPRANKS
·
Sep 15

Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development

GlobeNewswire
·
Sep 15

Neurizon Therapeutics Redeems 1 Million Convertible Notes Without Conversion

TIPRANKS
·
Sep 15

Immunology-Focused Biotech Electra Therapeutics Sets IPO Price Range at $14-$16 Per Share, Eyeing $325 Million Raise

Stock News
·
Sep 15

Prescient Therapeutics Extends Securities Purchase Plan Deadline

TIPRANKS
·
Sep 15